Clocortolone Pivalate - CAS 34097-16-0
Catalog number: B0084-475656
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C27H36ClFO5
Molecular Weight:
495.02
COA:
Inquire
Targets:
Others
Description:
Clocortolone Pivalate is a Corticosteroid Hormone Receptor Agonist. It is used for the treatment of dermatitis and is considered a medium-strength corticosteroid. It is unusual among steroids in that it contains a chlorine atom and a fluorine atom.
Ordering Information
Catalog Number Size Price Stock Quantity
B0084-475656 500 mg $298 In stock
Bulk Inquiry
Purity:
≥98%
Appearance:
White to pale yellow powder
Synonyms:
[2-[(6S,8S,9R,10S,11S,13S,14S,16R,17S)-9-chloro-6-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] 2,2-dimethylpropanoate;
Solubility:
Soluble in DMSO
Storage:
Store at -20 °C
MSDS:
Inquire
Application:
Clocortolone Pivalate is a Corticosteroid Hormone Receptor Agonist.
Quality Standard:
Enterprise standard/USP
Shelf Life:
As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly.
Quantity:
Milligrams-Grams
InChIKey:
SXYZQZLHAIHKKY-GSTUPEFVSA-N
InChI:
1S/C27H36ClFO5/c1-14-9-16-17-11-19(29)18-10-15(30)7-8-26(18,6)27(17,28)21(32)12-25(16,5)22(14)20(31)13-34-23(33)24(2,3)4/h7-8,10,14,16-17,19,21-22,32H,9,11-13H2,1-6H3/t14-,16+,17+,19+,21+,22-,25+,26+,27+/m1/s1
Canonical SMILES:
CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1C(=O)COC(=O)C(C)(C)C)C)O)Cl)C)F
1.Clinical utility of clocortolone pivalate for the treatment of corticosteroid-responsive skin disorders: a systematic review.
Singh S1, Mann BK. Clin Cosmet Investig Dermatol. 2012;5:61-8. doi: 10.2147/CCID.S23227. Epub 2012 Jun 22.
Clocortolone pivalate 0.1% cream is a class IV mid-strength topical glucocorticoid. After topical application the glucocorticoid achieves higher concentration in inflamed skin compared with normal skin. Furthermore, pharmacologic studies have shown that there is little systemic absorption of clocortolone pivalate and hence no adrenal suppression. Systematic review was performed to evaluate the efficacy and safety of the glucocorticoid. PubMed, the Cochrane Library, and individual websites of the top 20 dermatology journals were searched using a defined strategy. Following the selection criteria, eight clinical trials were selected, of which five were randomized controlled trials. The trials mainly included patients with atopic dermatitis and eczemas. Quality appraisal of randomized controlled trials was done using the Delphi list, which showed that the trials had weaknesses in several items. The results of the systematic review tend to show that clocortolone pivalate cream is generally effective with early onset of action and has a good safety profile in the treatment of these conditions.
2.The role of a midpotency topical corticosteroid and the clinical relevance of formulation characteristics in the management of commonly encountered eczematous and inflammatory dermatoses in adults and children: focus on the pharmacologic properties of clocortolone pivalate 0.1% cream.
Del Rosso JQ1, Kircik LH. J Drugs Dermatol. 2013 Feb;12(2):s5-s10.
Midpotency topical corticosteroids (TCSs) are frequently used for the treatment of common eczematous and inflammatory skin disorders in both adults and children. There are several commercially available products in this category, and many vehicles and formulations for the clinician to choose from. Clocortolone pivalate 0.1% cream is a midpotency TCS formulated in an emollient formulation that has been shown to be effective and well tolerated when used appropriately in the management of several corticosteroid-responsive dermatoses. This article discusses the physiochemical properties of the compound; the characteristics of its emollient cream formulation; the functions of individual excipients; and the efficacy, tolerability, and safety data supporting its use in adults and children, including for facial involvement.
3.Clocortolone pivalate: a topical corticosteroid with a unique structure.
Kircik LH1. J Drugs Dermatol. 2013 Feb;12(2):s3-4.
As the accumulated clinical evidence and experience to be presented in the next several pages demonstrate, the unique engineering of the clocortolone pivalate molecule balances potency with documented efficacy and a favorable safety profile. Clocortolone pivalate 0.1% cream is a well-formulated and versatile therapeutic option to consider for many of our patients with steroid-responsive dermatoses.
4.Transitioning from brand to generic with topical products and the importance of maintaining the formulation and therapeutic profiles of the original product: focus on clocortolone pivalate 0.1% cream.
Del Rosso JQ, Kircik LH. J Drugs Dermatol. 2014 Jul;13(7):s77-83.
Topical corticosteroids (TCSs) are a major part of the foundation of treatment for a wide variety of eczematous and inflammatory skin disorders in both adults and children. Mid-potency TCSs represent an important category as they are often used to treat eczematous dermatoses, such as atopic dermatitis. The TCS product must effectively release the active ingredient and promote cutaneous penetration so that therapeutic activity can occur. As many topical products eventually become available as generic formulations, it is important to recognize that although the active ingredient and its concentration are the same, the vehicle excipients may differ significantly, occasionally leading to potential differences in irritancy, in allergenicity, in effects on epidermal permeability barrier function, and, possibly, in efficacy. Clocortolone pivalate 0.1% cream is a mid-potency TCS formulated in an emollient formulation that has been shown to be effective and well-tolerated in the management of several corticosteroid-responsive dermatoses.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


CAS 83-40-9 3-Methylsalicylic acid

3-Methylsalicylic acid
(CAS: 83-40-9)

3-Methylsalicylic acid has marked fibrinolytic activity in human plasma by activating its fibrinolytic system. It is a salicylic acid derivative compound, which...

CAS 122008-78-0 Cyhalofop

Cyhalofop
(CAS: 122008-78-0)

Cyhalofop(Cyhalofop acid) is a recently registered herbicide from the aryloxyphenoxy propionate group in India to control a wide range of grass weed species at ...

AZD-5423
(CAS: 1034148-04-3)

AZD-5423 is a nonsteroidal glucocorticoid. It is used to treat respiratory diseases and in particular chronic obstructive pulmonary disease. It was developed by...

CAS 4910-46-7 N-Acetyl-β-Asp-Glu

N-Acetyl-β-Asp-Glu
(CAS: 4910-46-7)

N-Acetyl-β-Asp-Glu is a peptide neurotransmitter and the third-most-prevalent neurotransmitter in the mammalian nervous system.

CAS 21738-42-1 Oxamniquine

Oxamniquine
(CAS: 21738-42-1)

Oxamniquine, with schistosomicidal activity, is an antischistosomal drug used in the treatment of Schistosoma mansoni infection.

CAS 14154-42-8 Aluminum phthalocyanine chloride

Aluminum phthalocyanine chloride
(CAS: 14154-42-8)

Aluminum phthalocyanine chloride is an blue-green-coloured aromatic macrocyclic compound. It is widely used in dyeing. Phthalocyanine Chloroaluminum is a photos...

CAS 1360614-48-7 Necrosulfonamide

Necrosulfonamide
(CAS: 1360614-48-7)

Necrosulfonamide is a pharmacological inhibitor of MLKL with IC50 values of 124 nM in human HT-29, which significantly decreases BV6/DAC-induced cell death in M...

CAS 6233-83-6 Oxytocin acetate

Oxytocin acetate
(CAS: 6233-83-6)

Oxytocin acetate is a mammalian neurohypophysial hormone. Its actions are mediated by specific, high-affinity oxytocin receptors. Oxytocin is normally produced ...

Chemical Structure

CAS 34097-16-0 Clocortolone Pivalate

Quick Inquiry

Verification code

Featured Items